Kayne Anderson Rudnick Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-44
| Closed | -$3K | – | 612 |
|
|
2022
Q1 | $3K | Buy |
+44
| New | +$3K | ﹤0.01% | 578 |
|
|
2021
Q1 | – | Sell |
-9
| Closed | -$1K | – | 582 |
|
|
2020
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 582 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$85K | – | 551 |
|
|
2020
Q1 | $85K | Buy |
+1,000
| New | +$85K | ﹤0.01% | 374 |
|
|
2018
Q2 | – | Sell |
-138,165
| Closed | -$11.2M | – | 340 |
|
|
2018
Q1 | $11.2M | Sell |
138,165
-66,811
| -33% | -$5.42M | 0.08% | 163 |
|
|
2017
Q4 | $18.3M | Sell |
204,976
-18,806
| -8% | -$1.68M | 0.15% | 132 |
|
|
2017
Q3 | $20.8M | Sell |
223,782
-4,095
| -2% | -$381K | 0.19% | 119 |
|
|
2017
Q2 | $20.7M | Sell |
227,877
-5,517
| -2% | -$501K | 0.21% | 119 |
|
|
2017
Q1 | $20.5M | Sell |
233,394
-3,888
| -2% | -$341K | 0.22% | 123 |
|
|
2016
Q4 | $19.7M | Sell |
237,282
-9,905
| -4% | -$821K | 0.23% | 118 |
|
|
2016
Q3 | $22.9M | Buy |
247,187
+70,048
| +40% | +$6.48M | 0.29% | 102 |
|
|
2016
Q2 | $13.8M | Buy |
177,139
+38,187
| +27% | +$2.97M | 0.21% | 133 |
|
|
2016
Q1 | $11.5M | Buy |
138,952
+38,414
| +38% | +$3.17M | 0.19% | 135 |
|
|
2015
Q4 | $10.5M | Sell |
100,538
-3,494
| -3% | -$366K | 0.17% | 137 |
|
|
2015
Q3 | $11M | Buy |
104,032
+1,068
| +1% | +$112K | 0.19% | 131 |
|
|
2015
Q2 | $14.1M | Buy |
+102,964
| New | +$14.1M | 0.22% | 126 |
|